InvestorsHub Logo
Post# of 254821
Next 10
Followers 123
Posts 8886
Boards Moderated 0
Alias Born 10/05/2004

Re: None

Wednesday, 08/17/2022 2:19:28 PM

Wednesday, August 17, 2022 2:19:28 PM

Post# of 254821
BLUE - bluebird bio Announces FDA Approval of ZYNTEGLO®, the First Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusio

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.